Fcγ receptors: Structure, function and role as genetic risk factors in SLE

Genes and Immunity

Volumn 10, Issue 5, 2009, Pages 380-389

  Li, X ^a,b   Ptacek, T S ^a,c   Brown, E E ^a,d   Edberg, J C ^a  

^a The University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; FC RECEPTOR I; FC RECEPTOR IIA; FC RECEPTOR IIB; FC RECEPTOR IIC; FC RECEPTOR IIIA; FC RECEPTOR IIIB; OPSONIN; UNCLASSIFIED DRUG;

B LYMPHOCYTE ACTIVATION; BINDING AFFINITY; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CROSSING OVER; GENE EXPRESSION; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCATION; GENE LOCUS; GENE SEQUENCE; GENE STRUCTURE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; GLYCOSYLATION; HUMAN; HUMORAL IMMUNITY; INNATE IMMUNITY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSCRIPTION REGULATION; ANIMAL; GENE DOSAGE; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY;

ANIMALS; GENE DOSAGE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, IGG;

EID: 67849092283     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2009.35     Document Type: Review

References (90)

1. Sestak AL, Shaver TS, Moser KL, Neas BR, Harley JB. Familial aggregation of lupus and autoimmunity in an unusual multiplex pedigree. J Rheumatol 1999; 26: 1495-1499.
2. Arnett FC, Familial SLE. The HLA System and the Genetics of Lupus Erythematosus 3rd ed Lea & Febiger: Philadelphia, 1987.
3. Vyse TJ, Todd JA. Genetic analysis of autoimmune disease. Cell 1996; 85: 311-318.
4. Buckman KJ, Moore SK, Ebbin AJ, Cox MB, Dubois EL. Familial systemic lupus erythematosus. Arch Intern Med 1978; 138: 1674-1676.
5. Lawrence JS, Martins CL, Drake GL. A family survey of lupus erythematosus. 1. Heritability. J Rheumatol 1987; 14: 913-921.
6. Deapen D, Escalante A, Weinrib L, Horwitz D, Bachman B, Roy-Burman P et al. A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum 1992; 35: 311-318.
7. Block SR, Winfield JB, Lockshin MD, D'Angelo WA, Christian CL. Studies of twins with systemic lupus erythematosus. A review of the literature and presentation of 12 additional sets. Am J Med 1975; 59: 533-552.
8. Reichlin M, Harley JB, Lockshin MD. Serologic studies of monozygotic twins with systemic lupus erythematosus. Arthritis Rheum 1992; 35: 457-464.
9. Cantor RM, Yuan J, Napier S, Kono N, Grossman JM, Hahn BH et al. Systemic lupus erythematosus genome scan: Support for linkage at 1q23, 2q33, 16q12-13, and 17q21-23 and novel evidence at 3p24, 10q23-24, 13q32, and 18q22-23. Arthritis Rheum 2004; 50: 3203-3210.
10. Johanneson B, Lima G, von Salome J, Alarcon-Segovia D, Alarcon-Riquelme ME. A major susceptibility locus for systemic lupus erythemathosus maps to chromosome 1q31. Am J Hum Genet 2002; 71: 1060-1071.
11. Moser KL, Neas BR, Salmon JE, Yu H, Gray-McGuire C, Asundi N et al Genome scan of human systemic lupus erythematosus: Evidence for linkage on chromosome 1q in African-American pedigrees. Proc Natl Acad Sci USA 1998; 95: 14869-14874.
12. Olson JM, Song Y, Dudek DM, Moser KL, Kelly JA, Bruner GR et al. A genome screen of systemic lupus erythematosus using affected-relative-pair linkage analysis with covariates demonstrates genetic heterogeneity. Genes Immun 2002; 3(Suppl 1): S5-S12.
13. Shai R, Quismorio Jr FP, Li L, Kwon OJ, Morrison J, Wallace DJ et al Genome-wide screen for systemic lupus erythematosus susceptibility genes in multiplex families. Hum Mol Genet 1999; 8: 639-644.
14. Tsao BP, Cantor RM, Kalunian KC, Chen CJ, Badsha H, Singh R et al. Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus. J Clin Invest 1997; 99: 725-731.
15. Tsao BP. Lupus susceptibility genes on human chromosome 1. Int Rev Immunol 2000; 19: 319-334.
16. Hamburger MI, Lawley TJ, Kimberly RP, Plotz PH, Frank MM. A serial study of splenic reticuloendothelial system Fc receptor functional activity in systemic lupus erythematosus. Arthritis Rheum 1982; 25: 48-54.
17. Frank MM, Hamburger MI, Lawley TJ, Kimberly RP, Plotz PH. Defective reticuloendothelial system Fc-receptor function in systemic lupus erythematosus. N Engl J Med 1979; 300: 518-523.
18. Salmon JE, Kimberly RP, Gibofsky A, Fotino M. Defective mononuclear phagocyte function in systemic lupus erythematosus: Dissociation of Fc receptor-ligand binding and internalization. J Immunol 1984; 133: 2525-2331.
19. Nimmerjahn F, Ravetch JV. Fc-receptors as regulators of immunity. Nat Rev Immunol 2008; 8: 34-47.
20. Croker JA, Kimberly RP. Genetics of susceptibility and severity in systemic lupus erythematosus. Curr Opin Rheumatol 2005; 17: 529-537.
21. Salmon JE, Edberg JC, Brogle NL, Kimberly RP. Allelic polymorphisms of human Fc gamma receptor IIA and Fc gamma receptor IIIB. Independent mechanisms for differences in human phagocyte function. J Clin Invest 1992; 89: 1274-1281.
22. Salmon JE, Edberg JC, Kimberly RP. Fc gamma receptor III on human neutrophils. Allelic variants have functionally distinct capacities. J Clin Invest 1990; 85: 1287-1295.
23. Ernst LK, van de Winkel JG, Chiu IM, Anderson CL. Three genes for the human high affinity Fc receptor for IgG (Fc gamma RI) encode four distinct transcription products. J Biol Chem 1992; 267: 15692-15700.
24. Hoffmeyer F, Witte K, Schmidt RE. The high-affinity Fc gamma RI on PMN: regulation of expression and signal transduction. Immunology 1997; 92: 544-552.
25. Capel PJ, van de Winkel JG, van den Herik-Oudijk IE, Verbeek JS. Heterogeneity of human IgG Fc receptors. Immunomethods 1994; 4 25-34.
26. Ernst LK, Metes D, Herberman RB, Morel PA. Allelic polymorphisms in the FcgammaRIIC gene can influence its function on normal human natural killer cells. J Mol Med 2002; 80: 248-257.
27. Breunis WB, van Mirre E, Bruin M, Geissler J, de Boer M, Peters M et al. Copy number variation of the activating FCGR2C gene predisposes to idiopathic thrombocytopenic purpura. Blood 2008; 111: 1029-1038.
28. Simmons D, Seed B. The Fc gamma receptor of natural killer cells is a phospholipid-linked membrane protein. Nature 1998; 333: 568-570.
29. Bruhns P, Iannascoli B, England P, Mancardi DA, Fernandez N, Jorieux S et al. Specificity and affinity of human Fc{gamma} receptors and their polymorphic variants for human IgG subclasses. Blood 2009; 113: 3716-3725.
30. Ghazizadeh S, Bolen JB, Fleit HB. Tyrosine phosphorylation and association of Syk with Fc gamma RII in monocytic THP-1 cells. Biochem J 1995; 305: 669-674.
31. Ghazizadeh S, Bolen JB, Fleit HB. Physical and functional association of Src-related protein tyrosine kinases with Fc gamma RII in monocytic THP-1 cells. J Biol Chem 1994; 269: 8878-8884.
32. Bezman N, Koretzky GA. Compartmentalization of ITAM and integrin signaling by adapter molecules. Immunol Rev 2007; 218: 9-28.
33. Odin JA, Edberg JC, Painter CJ, Kimberly RP, Unkeless JC. Regulation of phagocytosis and [Ca2+]i flux by distinct regions of an Fc receptor. Science 1991; 254: 1785-1788.
34. Liao F, Shin HS, Rhee SG. Tyrosine phosphorylation of phospholipase C-gamma 1 induced by cross-linking of the high-affinity or low-affinity Fc receptor for IgG in U937 cells. Proc Natl Acad Sci USA 1992; 89: 3659-3663.
35. Kimberly RP, Wu J, Gibson AW, Su K, Qin H, Li X et al. Diversity and duplicity: Human Fcg receptors in host defense and autoimmunity. Immunol Res 2002; 26: 177-189.
36. Takai T. Roles of Fc receptors in autoimmunity. Nat Rev Immunol 2002; 2: 580-592.
37. van Vugt MJ, Kleijmeer MJ, Keler T, Zeelenberg I, van Dijk MA, Leusen JH et al. The FcγRIa (CD64) ligand binding chain triggers major histocompatibility complex class II antigen presentation independently of its associated FcR gamma-chain. Blood 1999; 94: 808-817.
38. Li X, Su K, Ji C, Szalai AJ, Wu J, Zhang Y et al. Immune opsonins modulate BlyS/BAFF release in a receptor-specific fashion. J Immunol 2008; 181: 1012-1018.
39. Bolland S, Ravetch JV. Inhibitory pathways triggered by ITIM-containing receptors. Adv Immunol 1999; 72: 149-177.
40. Bolland S, Ravetch JV. Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis. Immunity 2000; 13: 277-285.
41. McGaha TL, Sorrentino B, Ravetch JV. Restoration of tolerance in lupus by targeted inhibitory receptor expression. Science 2005; 307 590-593.
42. Barrow AD, Trowsdale J. You say ITAM and I say ITIM, let's call the whole thing off: The ambiguity of immunoreceptor signaling. Eur J Immunol 2006; 36: 1646-1653.
43. Ivanshikiv LB. Cross-regulation of signaling by ITAM-associated receptors. Nat Immunol 2009; 10: 340-347.
44. Hom G, Graham RR, Modrek B, Taylor KE, Ortmann W, Garnier S et al. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med 2008; 358: 900-909.
45. The International Consortium for Systemic Lupus Erythematosus Genetics (SLEGEN), Harley JB, Alarcon-Riquelme ME, Criswell LA, Jacob CO, Kimberly RP et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 2008; 40: 204-210.
46. Parren PW, Warmerdam PA, Boeije LC, Arts J, Westerdaal NA, Vlug A et al. On the interaction of IgG subclasses with the low affinity Fc gamma RIIa (CD32) on human monocytes, neutrophils, and platelets. Analysis of a functional polymorphism to human IgG2. J Clin Invest 1992; 90: 1537-1546.
47. Bredius RG, de Vries CE, Troelstra A, van Alphen L, Weening RS, van de Winkel JG et al. Phagocytosis of Staphylococcus aureus and Haemophilus influenzae type B opsonized with polyclonal human IgG1 and IgG2 antibodies. Functional hFc gamma RIIa polymorphism to IgG2. J Immunol 1993; 151: 1463-1472.
48. Duits AJ, Bootsma H, Derksen RH, Spronk PE, Kater L, Kallenberg CG et al. Skewed distribution of IgG Fc receptor IIa (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients. Arthritis Rheum 1995; 38: 1832-1836.
49. Salmon JE, Millard S, Schachter LA, Arnett FC, Ginzler EM, Gourley MF et al. Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans. J Clin Invest 1996; 97: 1348-1354.
50. Song YW, Han CW, Kang SW, Baek HJ, Lee EB, Shin CH et al. Abnormal distribution of Fc gamma receptor type IIa polymorphisms in Korean patients with systemic lupus erythematosus. Arthritis Rheum 1998; 41: 421-426.
51. Botto M, Theodoridis E, Thompson EM, Beynon HL, Briggs D, Isenberg DA et al. Fc gamma RIIa polymorphism in systemic lupus erythematosus (SLE): No association with disease. Clin Exp Immunol 1996; 104 264-268.
52. Smyth LJ, Snowden N, Carthy D, Papasteriades C, Hajeer A, Ollier WE. Fc gamma RIIa polymorphism in systemic lupus erythematosus. Ann Rheum Dis 1997; 56: 744-746.
53. Manger K, Repp R, Spriewald BM, Rascu A, Geiger A, Wassmuth R et al Fcgamma receptor IIa polymorphism in Caucasian patients with systemic lupus erythematosus: Association with clinical symptoms. Arthritis Rheum 1998; 41: 1181-1189.
54. Yap SN, Phipps ME, Manivasagar M, Tan SY, Bosco JJ. Human Fc gamma receptor IIA (FcgammaRIIA) genotyping and association with systemic lupus erythematosus (SLE) in Chinese and Malays in Malaysia. Lupus 1999; 8: 305-310.
55. Chen JY, Wang CM, Tsao KC, Chow YH, Wu JM, Li CL et al. Fcgamma receptor IIa, IIIa, and IIIb polymorphisms of systemic lupus erythematosus in Taiwan. Ann Rheum Dis 2004; 63: 877-880.
56. Karassa FB, Trikalinos TA, Ioannidis JP. Role of the Fcgamma receptor IIa polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis: A meta-analysis. Arthritis Rheum 2002; 46: 1563-1571.
57. Haseley LA, Wisnieski JJ, Denburg MR, Michael-Grossman AR, Ginzler EM, Gourley MF et al. Antibodies to C1q in systemic lupus erythematosus: Characteristics and relation to Fc gamma RIIA alleles. Kidney Int 1997; 52: 1375-1380.
58. Li X, Wu J, Carter RH, Edberg JC, Su K, Cooper GS et al. A novel polymorphism in the Fcgamma receptor IIB (CD32B) transmembrane region alters receptor signaling. Arthritis Rheum 2003; 48: 3242-3252.
59. Kyogoku C, Dijstelbloem HM, Tsuchiya N, Hatta Y, Kato H, Yamaguchi A et al. Fcgamma receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: Contribution of FCGR2B to genetic susceptibility. Arthritis Rheum 2002; 46: 1242-1254.
60. Kono H, Kyogoku C, Suzuki T, Tsuchiya N, Honda H, Yamamoto K et al FcgammaRIIB Ile232Thr transmembrane polymorphism associated with human systemic lupus erythematosus decreases affinity to lipid rafts and attenuates inhibitory effects on B cell receptor signaling. Hum Mol Genet 2005; 14: 2881-2892.
61. Floto RA, Clatworthy MR, Heilbronn KR, Rosner DR, MacAry PA, Rankin A et al. Loss of function of a lupus-associated FcgammaRIIb polymorphism through exclusion from lipid rafts. Nat Med 2005; 11: 1056-1058.
62. Chu ZT, Tsuchiya N, Kyogoku C, Ohashi J, Qian YP, Xu SB et al. Association of Fcgamma receptor IIb polymorphism with susceptibility to systemic lupus erythematosus in Chinese: A common susceptibility gene in the Asian populations. Tissue Antigens 2004; 63: 21-27.
63. Siriboonrit U, Tsuchiya N, Sirikong M, Kyogoku C, Bejrachandra S, Suthipinittharm P et al. Association of Fcgamma receptor IIb and IIIb polymorphisms with susceptibility to systemic lupus erythematosus in Thais. Tissue Antigens 2003; 61: 374-383.
64. Magnusson V, Zunec R, Odeberg J, Sturfelt G, Truedsson L, Gunnarsson I et al. Polymorphisms of the Fc gamma receptor type IIB gene are not associated with systemic lupus erythematosus in the Swedish population. Arthritis Rheum 2004; 50: 1348-1350.
65. Su K, Wu J, Edberg JC, Li X, Ferguson P, Cooper GS et al. A promoter haplotype of the immunoreceptor tyrosine-based inhibitory motif-bearing FcgammaRIIb alters receptor expression and associates with autoimmunity. I. Regulatory FCGR2B polymorphisms and their association with systemic lupus erythematosus. J Immunol 2004; 172: 7186-7191.
66. Su K, Li X, Edberg JC, Wu J, Ferguson P, Kimberly RP. A promoter haplotype of the immunoreceptor tyrosine-based inhibitory motif-bearing FcgammaRIIb alters receptor expression and associates with autoimmunity. II. Differential binding of GATA4 and Yin-Yang1 transcription factors and correlated receptor expression and function. J Immunol 2004; 172: 7192-7199.
67. Blank MC, Stefanescu RN, Masuda E, Marti F, King PD, Redecha PB et al Decreased transcription of the human FCGR2B gene mediated by the -343 G/C promoter polymorphism and association with systemic lupus erythematosus. Hum Genet 2005; 117: 220-227.
68. Vance BA, Huizinga TW, Wardwell K, Guyre PM. Binding of monomeric human IgG defines an expression polymorphism of Fc gamma RIII on large granular lymphocyte/natural killer cells. J Immunol 1993; 151 6429-6439.
69. Wu J, Edberg JC, Redecha PB, Bansal V, Guyre PM, Coleman K et al. A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease. J Clin Invest 1997; 100: 1059-1070.
70. Koene HR, Kleijer M, Algra J, Roos D, von dem Borne AE, de Haas M. Fc gammaRIIIa-158V/F polymorphism influences the binding of IgG by natural killer cell Fc gammaRIIIa, independently of the Fc gammaRIIIa-48 L/R/H phenotype. Blood 1997; 90: 1109-1114.
71. Alarcon GS, McGwin Jr G, Petri M, Ramsey-Goldman R, Fessler BJ, Vila LM et al. Time to renal disease and end-stage renal disease in PROFILE: A multiethnic lupus cohort. PLoS Med 2E06; 3: e396.
72. Ravetch JV, Perussia B. Alternative membrane forms of Fc gamma RIII(CD16) on human natural killer cells and neutrophils. Cell type-specific expression of two genes that differ in single nucleotide substitutions. J Exp Med 1989; 170: 481-497.
73. Hatta Y, Tsuchiya N, Ohashi J, Matsushita M, Fujiwara K, Hagiwara K et al. Association of Fc gamma receptor IIIB, but not of Fc gamma receptor IIA and IIIA polymorphisms with systemic lupus erythematosus in Japanese. Genes Immun 1999; 1: 53-60.
74. Ptacek T, Li X, Edberg JC. Copy number variants in genetic susceptibility and severity of systemic lupus erythematosus. Cytogenet Genome Res 2008; 123: 142-147.
75. Clark MR, Liu L, Carkson SB, Ory PA, Golstein IM. An abnormality of the gene that encodes neutrophil Fc receptor III in a patient with systemic lupus erythematosus. J clin Invest 1990; 86: 341-346.
76. Huizinga TWJ, Kuijpers RWAM, Kleijer M, Schulpen TWJ, Cuypers TM, Roos D et al. Maternal genomic neutrophil FcRIII deficiency leading to neonatal isoimmune neutropenia. Blood 1990; 76: 1927-1932.
77. Koene HR, Kleijer M, Roos D, de Haas M, Von dem Borne AEGKr. FcγRIIIB gene duplication: Evidence for presence and expression of three distinct FcgRIIIB genes in NA(1+,2+)Sh(+) individuals. Blood 1998; 91 673-679.
78. Aitman TJ, Dong R, Vyse TJ, Norsworthy PJ, Johnson MD, Smith J et al Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans. Nature 2006; 439: 851-855.
79. Fanciulli M, Norsworthy PJ, Petretto E, Dong R, Harper L, Kamesh L et al. FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific autoimmunity. Nat Genet 2007; 39: 721-723.
80. Willcocks LC, Lyons PA, Clatworthy MR, Robinson JI, Yang W, Newland SA et al. Copy number of FCGR3B, which is associated with systemic lupus erythematosus, correlates with protein expression and immune complex uptake. J Exp Med 2008; 205: 1573-1582.
81. de Haas M, Kleijer M, van Zwieten R, Roos D, von dem Borne AEGKr. Neutrophil FcγRIIIb deficiency, nature and clinical consequences: A study of 21 individuals from 14 families. Blood 1995; 86: 2403-2412.
82. Salmon JE, Ng S, Yoo DH, Kim TH, Kim SY, Song GG. Altered distribution of Fcgamma receptor IIIA alleles in a cohort of Korean patients with lupus nephritis. Arthritis Rheum 1999; 42: 818-819.
83. Vazquez-Doval J, Sanchez-Ibarrola A. Defective mononuclear phagocyte function in systemic lupus erythematosus: Relationship of FcRII (CD32) with intermediate cytoskeletal filaments. J Investig Allergol Clin Immunol 1993; 3: 86-91.
84. Seligman VA, Suarez C, Lum R, Inda SE, Lin D, Li H et al. The Fcgamma receptor IIIA-158F allele is a major risk factor for the development of lupus nephritis among Caucasians but not non-Caucasians. Arthritis Rheum 2001; 44: 618-625.
85. Clarkson SB, Kimberly RP, Valinsky JE, Witmer MD, Bussel JB, Nachman RL et al. Blockade of clearance of immune complexes by an anti-Fc gamma receptor monoclonal antibody. J Exp Med 1986; 164: 474-489.
86. Hong CH, Lee JS, Lee HS, Bae SC, Yoo DH. The association between fcgammaRIIIB polymorphisms and systemic lupus erythematosus in Korea. Lupus 2005; 14: 346-350.
87. Kyogoku C, Tsuchiya N, Wu H, Tsao BP, Tokunaga K. Association of Fcgamma receptor IIA, but not IIB and IIIA, polymorphisms with systemic lupus erythematosus: A family-based association study in Caucasians. Arthritis Rheum 2004; 50: 671-673.
88. Gittinger FS, Schindler-Wuepper L, Kissel K, Bux J. Quantitative determination of Fcgamma receptor genes by means of fluorescence-based real-time polymerase chain reaction. Tissue Antigens 2002; 60 64-70.
89. Price TH, Bowden RA, Boeckh M, Bux J, Nelson K, Liles WC et al. Phase I/II trial of neutrophil transfusions from donors stimulated with G-CSF and dexamethasone for treatment of patients with infections in hematopoietic stem cell transplantation. Blood 2000; 95: 3302-3309.
90. Inoue K, Lupski JR. Molecular mechanisms for genomic disorders. Annu Rev Genomics Hum Genet 2002; 3: 199-242.